HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan
· Delayed Price · Currency is TWD 52.00
-1.20 (-2.26%)
Mar 9, 2026, 2:12 PM CST
HeXun Biosciences Company Description
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.
It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services.
The company was founded in 2019 and is based in Taoyuan City, Taiwan.
HeXun Biosciences Co., Ltd.
| Country | Taiwan |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 45 |
| CEO | Ji-Hong Huang |
Contact Details
Address: No. 1490, Chunri Road Taoyuan City, 33022 Taiwan | |
| Phone | 886 3 317 5088 |
| Website | hexunbio.com |
Stock Details
| Ticker Symbol | 6986 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006986003 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Ji-Hong Huang | President and Chairman |
| Yushen Lan | Accounting and Finance Director |
| Arvin Chen | Vice President of Technology Management |
| Fred Cheng | Director of Administration |